share_log

Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)

Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)

礼来 | SC TO-T/A：发行招标公告
美股SEC公告 ·  08/01 06:12
Moomoo AI 已提取核心信息
Eli Lilly and Company, through its wholly-owned subsidiary Rainier Acquisition Corporation, has launched a tender offer to acquire all outstanding shares of Morphic Holding, Inc. at a price of $57.00 per share in cash. The offer, which commenced on July 19, 2024, is set to expire at 11:59 P.M., Eastern Time, on August 15, 2024, unless extended or terminated earlier. A key condition for the offer, the Regulatory Condition, was met with the expiration of the HSR Act waiting period on July 31, 2024. The completion of the tender offer is subject to other conditions detailed in the Offer to Purchase. The offer represents a strategic move by Eli Lilly to expand its holdings, and the acquisition process is being overseen by executives Anat Hakim and Michael C. Thompson, with legal counsel provided by Kirkland & Ellis LLP.
Eli Lilly and Company, through its wholly-owned subsidiary Rainier Acquisition Corporation, has launched a tender offer to acquire all outstanding shares of Morphic Holding, Inc. at a price of $57.00 per share in cash. The offer, which commenced on July 19, 2024, is set to expire at 11:59 P.M., Eastern Time, on August 15, 2024, unless extended or terminated earlier. A key condition for the offer, the Regulatory Condition, was met with the expiration of the HSR Act waiting period on July 31, 2024. The completion of the tender offer is subject to other conditions detailed in the Offer to Purchase. The offer represents a strategic move by Eli Lilly to expand its holdings, and the acquisition process is being overseen by executives Anat Hakim and Michael C. Thompson, with legal counsel provided by Kirkland & Ellis LLP.
伊莱利莉公司通过其全资子公司Rainier Acquisition Corporation发起了要约收购Morphic Holding公司所有未流通股票，每股现金价为57.00美元。该要约于2024年7月19日开始，除非提前终止或延长，否则将于2024年8月15日晚上11:59（美国东部时间）到期。作为该要约的关键条件，监管条件已在2024年7月31日HRS法案等待期满后满足。要约的完成还受Offer to Purchase中详细说明的其他条件的影响。此次要约收购是伊莱利莉公司扩大其持股的战略举措，Anat Hakim和Michael C. Thompson负责监督收购过程，其法律顾问是Kirkland & Ellis LLP。
伊莱利莉公司通过其全资子公司Rainier Acquisition Corporation发起了要约收购Morphic Holding公司所有未流通股票，每股现金价为57.00美元。该要约于2024年7月19日开始，除非提前终止或延长，否则将于2024年8月15日晚上11:59（美国东部时间）到期。作为该要约的关键条件，监管条件已在2024年7月31日HRS法案等待期满后满足。要约的完成还受Offer to Purchase中详细说明的其他条件的影响。此次要约收购是伊莱利莉公司扩大其持股的战略举措，Anat Hakim和Michael C. Thompson负责监督收购过程，其法律顾问是Kirkland & Ellis LLP。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息